The U.S. Food and Drug Administration (FDA) has given the okay to an app designed to help clinicians diagnose autism in children, labeling it safe for use. But it’s still unclear whether the technology is effective, researchers say, raising concerns that it could actually disrupt the standard diagnosis process and, in some cases, lead to delays in starting therapy.
Latest News Stories
- Disabled young people report on the challenges of using transport
- Disability minister is ‘drawing up a list’ of potential actions to address barriers
- Creating can shift perceptions in many ways
- 100 families appeal SEND council decisions
- Primark launches clothing range designed for people with disabilities